Aarey Drugs & Pharmaceuticals Share Price
94.44+0.00 (+2.97%)
+35.65% past 1 Year
News
Aarey Drugs & Pharma reports Profit after tax of 1.56 Crores, in the March 2026 quarter
Equity
AAREYDRUGS
Aarey Drugs & Pharmaceuticals informs about board meeting
Equity
AAREYDRUGS
Aarey Drugs & Pharma reports Profit after tax of 1.02 Crores, in the September 2025 quarter
Equity
AAREYDRUGS
Aarey Drugs & Pharma reports Profit after tax of 1.37 Crores, in the June 2025 quarter
Equity
AAREYDRUGS
Aarey Drugs & Pharma - Quaterly Results
Equity
AAREYDRUGS
Aarey Drugs & Pharma - Quaterly Results
Equity
AAREYDRUGS
Aarey Drugs & Pharmaceuticals informs about audited financial results
Equity
AAREYDRUGS
Aarey Drugs & Pharma reports Profit after tax of 47.00 Lakhs, in the March 2025 quarter
Equity
AAREYDRUGS
Aarey Drugs & Pharmaceuticals informs about EGM
Equity
AAREYDRUGS
Aarey Drugs & Pharma reports Profit after tax of 1.60 Crores, in the September 2024 quarter
Equity
AAREYDRUGS
Aarey Drugs & Pharmaceuticals informs about financial results
Equity
AAREYDRUGS
Aarey Drugs & Pharmaceuticals informs about certificate
Equity
AAREYDRUGS
Aarey Drugs & Pharma reports Profit after tax of 2.15 Crores, in the March 2024 quarter
Equity
AAREYDRUGS
Aarey Drugs & Pharmaceuticals informs about disclosure
Equity
AAREYDRUGS
Aarey Drugs and Pharmaceuticals informs about statement of no deviation and variation
Equity
AAREYDRUGS
Aarey Drugs & Pharma - Quaterly Results
Equity
AAREYDRUGS
Aarey Drugs & Pharma reports Profit after tax of 1.91 Crores, in the December 2023 quarter
Equity
AAREYDRUGS
Aarey Drugs & Pharma - Quaterly Results
Equity
AAREYDRUGS
Aarey Drugs & Pharma reports Profit after tax of 78.40 Lakhs, in the September 2023 quarter
Equity
AAREYDRUGS
Aarey Drugs & Pharmaceuticals informs about certificate
Equity
AAREYDRUGS